Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia

DNA methyltransferase 3B (DNMT3B) plays a critical role in cellular development and differentiation by maintaining genomic stability and silencing repetitive elements. However, emerging evidence highlights its oncogenic roles in driving aberrant DNA methylation (DNAm) patterns, activating oncogenes, and silencing tumor suppressor genes. Overexpression of DNMT3B is associated with poor prognosis and survival in Acute Myeloid Leukemia (AML). In both adult and pediatric AML cases, patients with DNMT3B expression above the median exhibit significantly fewer complete remissions (p < 0.05) and shorter overall survival (p < 0.01).

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jbc.2025.108718
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia

Kimberly Stephens, Samrat Roy Choudhury, Pritam Biswas, Akhilesh Kaushal
1 citations
Journal of Biological Chemistry
Acute Myeloid Leukemia Research
1.77
article

Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia

Kimberly Stephens, Samrat Roy Choudhury, Pritam Biswas, Akhilesh Kaushal
article en
1 citations

Abstract

DNA methyltransferase 3B (DNMT3B) plays a critical role in cellular development and differentiation by maintaining genomic stability and silencing repetitive elements. However, emerging evidence highlights its oncogenic roles in driving aberrant DNA methylation (DNAm) patterns, activating oncogenes, and silencing tumor suppressor genes. Overexpression of DNMT3B is associated with poor prognosis and survival in Acute Myeloid Leukemia (AML). In both adult and pediatric AML cases, patients with DNMT3B expression above the median exhibit significantly fewer complete remissions (p < 0.05) and shorter overall survival (p < 0.01).

Journal of Biological ChemistryVol. 301(5)
University of Alabama at Birmingham (US), University of Arkansas for Medical Sciences (US)
Openalex Percentile: Top 15%
Acute Myeloid Leukemia Research
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.